Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2022-11-02 00:00:00 ET · period of report 2022-10-31 · accession 0001883850-22-000086 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-11-02 | 2022-11-01 | REGN | Landry Robert E | EVP Fin CFO | S - Sale+OE | $758.06 | -482 | 28.8K | -2% | -$365.4K |
| D | 2022-11-02 | 2022-10-31 | REGN | Landry Robert E | EVP Fin CFO | M - OptEx | $381.92 | +2,000 | 30.7K | +7% | +$763.8K |
| D | 2022-11-02 | 2022-10-31 | REGN | Landry Robert E | EVP Fin CFO | F - Tax | $751.24 | -1,518 | 29.2K | -5% | -$1.14M |
| D | 2022-11-02 | 2022-10-31 | REGN | Landry Robert E | EVP Fin CFO | M - OptEx | $0.00 | -2,000 | 9,300 | -18% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-01 | S | D | 80 | $754.39 | 29,105 | D | — | — | (F2) Represents volume-weighted average price of sales of 80 shares of Company stock on November 1, 2022 at prices ranging from $754.20 to $754.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price. |
| 2 | Common | Common Stock | 2022-11-01 | S | D | 19 | $763.10 | 28,744 | D | — | — | |
| 3 | Common | Common Stock | 2022-11-01 | S | D | 17 | $762.92 | 28,763 | D | — | — | |
| 4 | Common | Common Stock | 2022-10-31 | M | A | 2,000 | $381.92 | 30,744 | D | — | — | |
| 5 | Common | Common Stock | 2022-10-31 | F | D | 1,518 | $751.24 | 29,226 | D | — | — | |
| 6 | Common | Common Stock | 2022-11-01 | S | D | 1 | $750.00 | 29,225 | D | — | — | |
| 7 | Common | Common Stock | 2022-11-01 | S | D | 40 | $753.23 | 29,185 | D | — | — | |
| 8 | Common | Common Stock | 2022-11-01 | S | D | 81 | $755.46 | 29,024 | D | — | — | (F3) Represents volume-weighted average price of sales of 81 shares of Company stock on November 1, 2022 at prices ranging from $755.03 to $755.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price. |
| 9 | Common | Common Stock | 2022-11-01 | S | D | 42 | $758.20 | 28,982 | D | — | — | (F4) Represents volume-weighted average price of sales of 42 shares of Company stock on November 1, 2022 at prices ranging from $758.15 to $758.67. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price. |
| 10 | Common | Common Stock | 2022-11-01 | S | D | 70 | $759.39 | 28,912 | D | — | — | (F5) Represents volume-weighted average price of sales of 70 shares of Company stock on November 1, 2022 at prices ranging from $759.23 to $759.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price. |
| 11 | Common | Common Stock | 2022-11-01 | S | D | 13 | $760.90 | 28,899 | D | — | — | (F6) Represents volume-weighted average price of sales of 13 shares of Company stock on November 1, 2022 at prices ranging from $760.81 to $760.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price. |
| 12 | Common | Common Stock | 2022-11-01 | S | D | 119 | $761.36 | 28,780 | D | — | — | (F7) Represents volume-weighted average price of sales of 119 shares of Company stock on November 1, 2022 at prices ranging from $761.19 to $761.44. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price. |
| 13 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-10-31 | M | D | 2,000 | $0.00 | 9,300 | D | $381.92 · — to 2026-12-16 | 2,000 Common Stock | (F8) The stock option award vests in four equal annual installments, commencing one year after the date of grant. |